Drug data last refreshed 7h ago · AI intelligence enriched 3w ago
NITROGEN, NF is an inhaled nitrogen gas product approved as a pharmaceutical in 2013 by the FDA under an NDA submitted by Advanced Solutions Life Sciences. The specific clinical indications and mechanism of action are not publicly detailed in standard databases, suggesting a specialized or niche therapeutic use. As an inhalation gas, it represents a non-traditional pharmaceutical modality.
Product is in peak lifecycle stage with minimal competitive pressure (30%), though limited commercial data suggests a niche market with modest team resource allocation.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts
Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts
Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care
Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness
The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients
Worked on NITROGEN, NF at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
NITROGEN, NF represents a highly specialized niche product with minimal linked job postings (0), indicating a small, focused commercial footprint and limited career mobility within the brand. Career growth will depend on expansion into new indications or market expansion rather than scaling.